Hereditary motor and sensory neuropathies: a biological perspective
暂无分享,去创建一个
[1] J. Julien,et al. Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments , 1997, Experimental Neurology.
[2] Steven H Y Hsieh,et al. Regional modulation of neurofilament organization by myelination in normal axons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] M. Koenig,et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy , 2000, Nature Genetics.
[4] F. Gabreëls,et al. Allelic heterogeneity in hereditary motor and sensory neuropathy type la (Charcot‐Marie‐Tooth disease type 1a) , 1993, Neurology.
[5] F. Baas,et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies , 1994, Nature Genetics.
[6] B. Trapp,et al. Role of myelin Po protein as a homophilic adhesion molecule , 1990, Nature.
[7] J. Lupski,et al. Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital Hypomyelination , 1996, Neuron.
[8] S. Scherer,et al. On the molecular architecture of myelinated fibers , 2000, Histochemistry and Cell Biology.
[9] P. Dyck,et al. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. , 1968, Archives of neurology.
[10] J. Lupski,et al. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot‐Marie‐Tooth disease , 1996, Human mutation.
[11] C. van Broeckhoven,et al. Further evidence that neurofilament light chain gene mutations can cause Charcot‐Marie‐Tooth disease type 2E , 2001, Annals of neurology.
[12] P. Dyck,et al. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. , 1968, Archives of neurology.
[13] M. Watson,et al. EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene Expression , 2001, Neuron.
[14] E. Dupin,et al. Cell lineage analysis in neural crest ontogeny. , 1993, Journal of neurobiology.
[15] C. Disteche,et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies , 1993, Cell.
[16] D. Sherman,et al. Two PDZ Domain Proteins Encoded by the Murine Periaxin Gene Are the Result of Alternative Intron Retention and Are Differentially Targeted in Schwann Cells* , 1998, The Journal of Biological Chemistry.
[17] L. Kalaydjieva,et al. A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. , 2000, American journal of human genetics.
[18] A. Aguayo,et al. Myelination of mouse axons by Schwann cells transplanted from normal and abnormal human nerves , 1977, Nature.
[19] D. Sherman,et al. A Tripartite Nuclear Localization Signal in the PDZ-domain Protein L-periaxin* , 2000, The Journal of Biological Chemistry.
[20] Peter J. Brophy,et al. Periaxin, a novel protein of myelinating schwann cells with a possible role in axonal ensheathment , 1994, Neuron.
[21] K. Nave,et al. A Transgenic Rat Model of Charcot-Marie-Tooth Disease , 1996, Neuron.
[22] O. Combarros,et al. Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood , 1998, Neurology.
[23] S. Botti,et al. Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation , 2000, Neurology.
[24] V. Ionasescu,et al. Screening of dominantly inherited Charcot–Marie–Tooth neuropathies , 1993, Muscle & nerve.
[25] J. Mendell,et al. Effects of PMP22 duplication and deletions on the axonal cytoskeleton , 1999, Annals of neurology.
[26] T. Uchida,et al. Isolation of 10 Differentially Expressed cDNAs in Differentiated Neuro2a Cells Induced Through Controlled Expression of the GD3 Synthase Gene , 1999, Journal of Neurochemistry.
[27] E. Bellone,et al. A Novel Mutation (D305V) in the early growth response 2 gene is associated with severe Charcot‐Marie‐Tooth type 1 disease , 1999 .
[28] W. Bradley,et al. The peroneal muscular atrophy syndrome Clinical, genetic, electrophysiological and nerve biopsy studies part 3. Clinical, electrophysiological and pathological correlations , 1977, Journal of the Neurological Sciences.
[29] Q. Yan,et al. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons , 1995, Nature.
[30] W. Hendrickson,et al. Crystal Structure of the Extracellular Domain from P0, the Major Structural Protein of Peripheral Nerve Myelin , 1996, Neuron.
[31] C. Lacroix,et al. The Roussy‐Lévy family: From the original description to the gene , 1999, Annals of neurology.
[32] I. Marín,et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease , 2002, Nature Genetics.
[33] Sylvie M. de Waegh,et al. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] D. Sherman,et al. Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. , 1995, Development.
[35] J. Kamholz,et al. Axons regulate Schwann cell expression of the POU transcription factor SCIP , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] A. Windebank,et al. Congenital hypomyelination due to myelin protein zero Q215X mutation , 1999, Annals of neurology.
[37] J. Mandel,et al. The myotubularin family: from genetic disease to phosphoinositide metabolism. , 2001, Trends in genetics : TIG.
[38] A. Aguzzi,et al. Distal axonopathy in peripheral nerves of PMP22-mutant mice. , 1999, Brain : a journal of neurology.
[39] J. Lupski,et al. Dejerine–Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene , 1993, Nature Genetics.
[40] M. Rosenfeld,et al. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. , 1996, Genes & development.
[41] Virginia M. Y. Lee,et al. Formation of Compact Myelin Is Required for Maturation of the Axonal Cytoskeleton , 1999, The Journal of Neuroscience.
[42] D. Sherman,et al. Specific Disruption of a Schwann Cell Dystrophin-Related Protein Complex in a Demyelinating Neuropathy , 2001, Neuron.
[43] J. Lupski,et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. , 1993, The New England journal of medicine.
[44] K. Offord,et al. The nature of myelinated nerve fiber degeneration in dominantly inherited hypertrophic neuropathy. , 1974, Mayo Clinic proceedings.
[45] R. Axel,et al. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin , 1985, Cell.
[46] A. Mégarbané,et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. , 2001, Human molecular genetics.
[47] S M Leber,et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. , 2001, American journal of human genetics.
[48] G. Sobue,et al. A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot–Marie–Tooth disease type 1 , 2001, Journal of the Neurological Sciences.
[49] M. Filbin,et al. The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain , 1994, The Journal of cell biology.
[50] A. Asbury,et al. Giant axonal neuropathy — A unique case with segmental neurofilamentous masses , 2004, Acta Neuropathologica.
[51] J. Lupski,et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies , 1998, Nature Genetics.
[52] P K Thomas,et al. The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.
[53] M. Pericak-Vance,et al. Hereditary motor and sensory neuropathy, X‐linked , 1987, Neurology.
[54] R. G. Harrison. Neuroblast versus sheath cell in the development of peripheral nerves , 1924 .
[55] K. Fischbeck,et al. Connexin32‐null mice develop demyelinating peripheral neuropathy , 1998, Glia.
[56] Ram K. Sihag,et al. Local Control of Neurofilament Accumulation during Radial Growth of Myelinating Axons in Vivo , 2000, The Journal of cell biology.
[57] V. Ionasescu,et al. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene , 1995, Neurology.
[58] S. Scherer,et al. The Transcription Factors SCIP and Krox-20 Mark Distinct Stages and Cell Fates in Schwann Cell Differentiation , 1996, Molecular and Cellular Neuroscience.
[59] J. Ott,et al. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. , 1982, American journal of human genetics.
[60] M. Shy,et al. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis , 2000, Journal of neuroscience research.
[61] S. Scherer. The biology and pathobiology of Schwann cells. , 1997, Current opinion in neurology.
[62] W. Bradley,et al. Childhood giant axonal neuropathy case report and review of the literature , 1987, Journal of the Neurological Sciences.
[63] S. Scherer. Molecular specializations at nodes and paranodes in peripheral nerve , 1996, Microscopy research and technique.
[64] W. Brown,et al. X-linked dominant hereditary motor and sensory neuropathy. , 1990, Brain : a journal of neurology.
[65] C. van Broeckhoven,et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. , 1999, Brain : a journal of neurology.
[66] Aldo Quattrone,et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.
[67] O. Evgrafov,et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.
[68] J. Griffin,et al. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot‐Marie‐Tooth disease type 1 , 1994, Neurology.
[69] W. Bradley,et al. The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. , 1978, Journal de genetique humaine.
[70] T. Crawford,et al. Localization of the giant axonal neuropathy gene to chromosome 16q24 , 1998, Annals of neurology.
[71] N. Wood,et al. Dejerine‐sottas neuropathy and PMP22 point mutations: A new base pair substitution and a possible “hot spot” on Ser72 , 1998, Annals of neurology.
[72] S. Scherer,et al. Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. , 2000, Brain : a journal of neurology.
[73] R. Oppenheim,et al. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.
[74] C. van Broeckhoven,et al. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies , 1999, Human mutation.
[75] N. Hirokawa,et al. Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.
[76] F. Gabreëls,et al. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I) , 1992, Journal of the Neurological Sciences.
[77] T. Crawford,et al. Neurofilament distribution and organization in the myelinated axons of the peripheral nervous system , 1994, Brain Research.
[78] F. Muntoni,et al. Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. , 1997, Brain : a journal of neurology.
[79] R. Mirsky,et al. Schwann cell development, differentiation and myelination , 1996, Current Opinion in Neurobiology.
[80] M. Schachner,et al. Mouse P 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons , 1992, Cell.
[81] F. Baas,et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) , 1991, Neuromuscular Disorders.
[82] Jean-Pierre Julien,et al. Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H , 2000, Brain Research.
[83] Aravinda Chakravarti,et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.
[84] V. Timmerman,et al. Charcot‐Marie‐Tooth Neuropathy Type 2 and P0 Point Mutations: Two Novel Amino Acid Substitutions (Asp61Gly; Tyr119Cys) and a Possible “Hotspot” on Thr124Met , 2000, Brain pathology.
[85] J. Riggs,et al. Evolution of nerve conduction abnormalities in children with dominant hypertrophic neuropathy of the charcot‐marie‐tooth type , 1983, Muscle & nerve.
[86] M. Shy,et al. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination , 2001, The Journal of cell biology.
[87] F. Muntoni,et al. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene , 1998, Neurology.
[88] A. Quattrone,et al. Autosomal Recessive Hereditary Motor and Sensory Neuropathy with Focally Folded Myelin Sheaths (CMT4B) , 1999, Annals of the New York Academy of Sciences.
[89] J. Gilbert,et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 , 2002, Nature Genetics.
[90] S. Schneider-Maunoury,et al. Krox-20 controls myelination in the peripheral nervous system , 1994, Nature.
[91] U. Suter,et al. Heterozygous Peripheral Myelin Protein 22-Deficient Mice Are Affected by a Progressive Demyelinating Tomaculous Neuropathy , 1997, The Journal of Neuroscience.
[92] S. Hinderer,et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.
[93] K. Campbell,et al. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve , 1994, FEBS letters.
[94] A. Harding,et al. The phenotypic manifestations of chromosome 17p11.2 duplication. , 1997, Brain : a journal of neurology.
[95] M. Filbin,et al. Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain , 1996, The Journal of cell biology.
[96] C. van Broeckhoven,et al. Identification of a 5' splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. , 1994, Human molecular genetics.
[97] J. Lupski,et al. Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype , 1999, Neurology.
[98] R. Lovelace,et al. CLINICAL AND ELECTRODIAGNOSTIC FEATURES OF CHARCOT‐MARIE‐TOOTH SYNDROME , 1978, Acta neurologica Scandinavica. Supplementum.
[99] A. Brice,et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies , 1996, Annals of neurology.
[100] A. Aguzzi,et al. Impaired Differentiation of Schwann Cells in Transgenic Mice with Increased PMP22 Gene Dosage , 1996, The Journal of Neuroscience.
[101] A. Harding,et al. Genetic aspects of hereditary motor and sensory neuropathy (types I and II) , 1980, Journal of medical genetics.
[102] K. Willecke,et al. Structural Abnormalities and Deficient Maintenance of Peripheral Nerve Myelin in Mice Lacking the Gap Junction Protein Connexin 32 , 1997, The Journal of Neuroscience.
[103] M. Pericak-Vance,et al. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17 , 1989, Experimental Neurology.
[104] F. Buchthal,et al. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. , 1977, Brain : a journal of neurology.